{"id":62393,"date":"2025-01-28T10:19:56","date_gmt":"2025-01-28T15:19:56","guid":{"rendered":"https:\/\/www.businessupturn.com\/usa\/?p=62393"},"modified":"2025-01-28T12:27:10","modified_gmt":"2025-01-28T17:27:10","slug":"stock-market-today-vincerx-pharma-declined-by-95-75-whereas-revelation-biosciences","status":"publish","type":"post","link":"https:\/\/www.businessupturn.com\/usa\/stock-market-today-vincerx-pharma-declined-by-95-75-whereas-revelation-biosciences\/62393\/","title":{"rendered":"Stock market today: Vincerx Pharma declined by 95.75% whereas Revelation Biosciences plunged by 92.99% in early trading"},"content":{"rendered":"<p><span style=\"font-weight: 400\">As of 10:08 AM EST today, several biotech stocks saw dramatic price movements. Leading the list was <\/span><b>Vincerx Pharma, Inc.<\/b><span style=\"font-weight: 400\"> as it traded at <\/span><b>1.69 USD<\/b><span style=\"font-weight: 400\">, reflecting a decline of <\/span><b>95.75%<\/b><span style=\"font-weight: 400\">, with a market cap of <\/span><b>4.45 million USD<\/b><span style=\"font-weight: 400\">.\u00a0<\/span><\/p>\n<p><b>Revelation Biosciences, Inc.<\/b><span style=\"font-weight: 400\"> dropped <\/span><b>92.99%<\/b><span style=\"font-weight: 400\">, trading at <\/span><b>4.28 USD<\/b><span style=\"font-weight: 400\">, with a valuation of <\/span><b>1.99 million USD<\/b><span style=\"font-weight: 400\">. Similarly, <\/span><b>MiNK Therapeutics, Inc.<\/b><span style=\"font-weight: 400\"> fell <\/span><b>91.80%<\/b><span style=\"font-weight: 400\">, settling at <\/span><b>7.25 USD<\/b><span style=\"font-weight: 400\">, bringing its market cap to <\/span><b>35.03 million USD<\/b><span style=\"font-weight: 400\">.\u00a0<\/span><\/p>\n<p><b>Leap Therapeutics, Inc.<\/b><span style=\"font-weight: 400\"> declined <\/span><b>69.82%<\/b><span style=\"font-weight: 400\"> to <\/span><b>0.68 USD<\/b><span style=\"font-weight: 400\">, with a total valuation of <\/span><b>86.22 million USD<\/b><span style=\"font-weight: 400\">. The stock fell after disappointing initial data from two mid-stage clinical trials of its oncology treatment, which further led to the termination of one clinical program.Meanwhile, <\/span><b>Sharps Technology Inc.<\/b><span style=\"font-weight: 400\"> lost <\/span><b>68.15%<\/b><span style=\"font-weight: 400\">, trading at <\/span><b>0.47 USD<\/b><span style=\"font-weight: 400\">, with a market cap of <\/span><b>2.99 million USD<\/b><span style=\"font-weight: 400\">.<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u00a0Lastly, <\/span><b>SAB Biotherapeutics, Inc.<\/b><span style=\"font-weight: 400\"> recorded a decline of <\/span><b>48.00%<\/b><span style=\"font-weight: 400\">, reaching <\/span><b>2.27 USD<\/b><span style=\"font-weight: 400\">, with a total valuation of <\/span><b>40.24 million USD<\/b><span style=\"font-weight: 400\">.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Disclaimer: This article is for informational purposes only and does not constitute any financial advice.<\/span><\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Leading the list was Vincerx Pharma, Inc. as it traded at 1.69 USD, reflecting a decline of 95.75%, with a market cap of 4.45 million USD.\u00a0<\/p>\n","protected":false},"author":433,"featured_media":52609,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[73],"tags":[24578,24579,24054,24577,23709,24011],"class_list":["post-62393","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-us-markets","tag-leap-therapeutics","tag-mink-therapeutics","tag-revelation-biosciences","tag-sab-biotherapeutics","tag-sharps-technology","tag-vincerx-pharma"],"reading_time":"1 min read","_links":{"self":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts\/62393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/users\/433"}],"replies":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/comments?post=62393"}],"version-history":[{"count":0,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts\/62393\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/media\/52609"}],"wp:attachment":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/media?parent=62393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/categories?post=62393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/tags?post=62393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}